- Report
- September 2025
- 338 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- March 2025
- 294 Pages
Global
From €4050EUR$4,490USD£3,472GBP
- Report
- January 2025
- 291 Pages
Global
From €4510EUR$5,000USD£3,867GBP
- Report
- January 2025
- 286 Pages
Global
From €4510EUR$5,000USD£3,867GBP
- Report
- January 2023
- 343 Pages
Global
From €4510EUR$5,000USD£3,867GBP
- Report
- August 2025
- 82 Pages
India
From €3157EUR$3,500USD£2,707GBP
- Report
- August 2025
- 188 Pages
Global
From €4059EUR$4,500USD£3,480GBP
- Report
- May 2025
- 180 Pages
Global
From €4059EUR$4,500USD£3,480GBP
- Report
- April 2025
- 85 Pages
India
From €3157EUR$3,500USD£2,707GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3157EUR$3,500USD£2,707GBP
- Report
- February 2024
- 185 Pages
Global
From €4059EUR$4,500USD£3,480GBP
- Report
- October 2023
- 178 Pages
Global
From €4059EUR$4,500USD£3,480GBP
- Report
- October 2023
- 128 Pages
North America
From €3608EUR$4,000USD£3,093GBP
- Report
- September 2024
- 82 Pages
Japan
From €3157EUR$3,500USD£2,707GBP
- Report
- July 2024
- 150 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- July 2024
- 100 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- July 2024
- 100 Pages
Global
From €3382EUR$3,750USD£2,900GBP
- Report
- November 2023
- 30 Pages
Global
From €2931EUR$3,250USD£2,513GBP
- Report
- October 2024
- 200 Pages
Global
From €4464EUR$4,949USD£3,827GBP
- Report
- October 2024
- 200 Pages
Global
From €4464EUR$4,949USD£3,827GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more